For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
It’s a heartache
Wednesday 14 December 2022, 05:00 AM

Because everything seems simpler under fairy lights [Image: Olga Ubirailo on iStock]
Editor Barbara Fountain writes of primary care’s struggles trying not to come a gutser in COVID’s third year
This year has exhausted us all.
We thought the prior two years, with lockdowns and “traffic lights” and vaccine drives and boosters and video consu, Barbara Fountain, Barbara Fountain
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.